Market Overview:
The global spinal devices and biologics market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of spine disorders, rising geriatric population, and technological advancements in spinal devices and biologics. Based on type, the global spinal devices and biologics market is segmented into spinal fusion & fixation, motion preservation, non-fusion technologies, fracture treatment, and others. The non-fusion technologies segment is expected to grow at the highest CAGR during the forecast period owing to its growing popularity among surgeons for treating complex spine disorders. Based on application, the global spinal devices and biologics market is segmented into hospitals, ambulatory surgical centers (ASCs), clinics, and others. The hospitals segment accounted for the largest share of this market in 2017 owing to increased use of these products for complex surgeries such as spine fusion surgeries. However, the ASCs segment is projected to grow at a higher CAGR during 2018–2030 due its advantages over hospitals such as lower costs associated with procedures performed therein as well as shorter waiting times for patients seeking surgery.
Product Definition:
A spinal device is a medical device used to stabilize the spine or treat a spinal disorder. A biologic is a medication derived from natural sources, such as animal tissues, microorganisms, or plants. Biologics are also known as proteins, therapeutic antibodies, and growth factors.
Spinal Fusion & Fixation:
Spinal fusion and fixation is a surgical procedure that involves realigning the spine. It's main objective is to cure back pain, which can be caused due to degenerative disc disease or trauma. The surgery also aims at reducing lower back pain as well as providing stability to the spine by aligning the vertebrae in their proper position.
The global spinal fusion.
Motion Preservation:
Motion preservation and it's usage in spinal devices and biologics market is a technique used to stabilize a damaged spine by preventing or delaying degeneration of disc material. It is also known as interspinous process laminectomy procedure. This procedure involves the removal of small pieces of bone from between the vertebrae to reduce pain, improve motion, and increase range of motion in an attempt to cure back pain or neck pain.
Application Insights:
The hospitals segment dominated the global market in 2017. Hospitals are generally the most preferred location for spinal surgeries, as they offer advanced facilities and equipment for pain management and recovery. In addition, hospitals have a larger number of surgeons available to perform surgeries than other healthcare facilities. The presence of various healthcare providers at one location increases the chances of getting better results during surgery.
The clinics segment is expected to grow at a lucrative rate over the forecast period due to increasing awareness about minimally invasive procedures among patients seeking treatment outside their homes or hospital settings. According to an article published by Healthline, Minimally Invasive Spinal Surgery: A Growing Trend Outside Hospital Settings, in 2018 there were around 40 million visits annually by people with low back pain seeking care from primary care physicians outside their local hospitals or medical centers (clinics).
Regional Analysis:
North America dominated the global market in 2017. The presence of well-developed healthcare infrastructure, high disposable income, and favorable government initiatives are some of the major factors responsible for its large share. In addition, an increase in the number of patients suffering from spinal cord injuries has also contributed to its largest share. According to a study published by American Association for Spinal Cord Injury Care & Research Foundation (AASCCICR), around 285,000 people are reported to have been paralyzed due to various spinal cord injuries every year in U.S.
Asia Pacific is expected witness lucrative growth during the forecast period owing to increasing investments by governments and private players as well as rising awareness about advanced treatment options for spine disorders among patients.
Growth Factors:
- Increasing incidence of spinal cord injuries and disorders
- Growing demand for minimally invasive surgeries
- Rising awareness about the benefits of spinal devices and biologics
- Technological advancements in spinal implants and biologics
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Spinal Devices and Biologics Market Research Report
By Type
Spinal Fusion & Fixation, Motion Preservation, Non-Fusion Technologies, Fracture Treatment, Others
By Application
Hospitals, Ambulatory Surgical Centers, Clinics, Others
By Companies
Nuvasive, Orthofix International, Exactech, Wright Medical Group, Johnson & Johnson, Zimmer Biomet, Globus Medical, K2M, Medtronic, Alphatec Holdings, Nuvasive
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
214
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Spinal Devices and Biologics Market Report Segments:
The global Spinal Devices and Biologics market is segmented on the basis of:
Types
Spinal Fusion & Fixation, Motion Preservation, Non-Fusion Technologies, Fracture Treatment, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Nuvasive
- Orthofix International
- Exactech
- Wright Medical Group
- Johnson & Johnson
- Zimmer Biomet
- Globus Medical
- K2M
- Medtronic
- Alphatec Holdings
- Nuvasive
Highlights of The Spinal Devices and Biologics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Spinal Fusion & Fixation
- Motion Preservation
- Non-Fusion Technologies
- Fracture Treatment
- Others
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Spinal Devices and Biologics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Spinal devices and biologics are medical products that help people with spinal cord injuries or diseases. These products can include artificial limbs, crutches, wheelchairs, and other equipment. They may also include drugs that help people with spinal cord injuries or diseases regain movement or improve their quality of life.
Some of the key players operating in the spinal devices and biologics market are Nuvasive, Orthofix International, Exactech, Wright Medical Group, Johnson & Johnson, Zimmer Biomet, Globus Medical, K2M, Medtronic, Alphatec Holdings, Nuvasive.
The spinal devices and biologics market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Spinal Devices and Biologics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Spinal Devices and Biologics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Spinal Devices and Biologics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Spinal Devices and Biologics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Spinal Devices and Biologics Market Size & Forecast, 2018-2028
4.5.1 Spinal Devices and Biologics Market Size and Y-o-Y Growth
4.5.2 Spinal Devices and Biologics Market Absolute $ Opportunity
Chapter 5 Global Spinal Devices and Biologics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Spinal Devices and Biologics Market Size Forecast by Type
5.2.1 Spinal Fusion & Fixation
5.2.2 Motion Preservation
5.2.3 Non-Fusion Technologies
5.2.4 Fracture Treatment
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Spinal Devices and Biologics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Spinal Devices and Biologics Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Clinics
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Spinal Devices and Biologics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Spinal Devices and Biologics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Spinal Devices and Biologics Analysis and Forecast
9.1 Introduction
9.2 North America Spinal Devices and Biologics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Spinal Devices and Biologics Market Size Forecast by Type
9.6.1 Spinal Fusion & Fixation
9.6.2 Motion Preservation
9.6.3 Non-Fusion Technologies
9.6.4 Fracture Treatment
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Spinal Devices and Biologics Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Clinics
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Spinal Devices and Biologics Analysis and Forecast
10.1 Introduction
10.2 Europe Spinal Devices and Biologics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Spinal Devices and Biologics Market Size Forecast by Type
10.6.1 Spinal Fusion & Fixation
10.6.2 Motion Preservation
10.6.3 Non-Fusion Technologies
10.6.4 Fracture Treatment
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Spinal Devices and Biologics Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Clinics
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Spinal Devices and Biologics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Spinal Devices and Biologics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Spinal Devices and Biologics Market Size Forecast by Type
11.6.1 Spinal Fusion & Fixation
11.6.2 Motion Preservation
11.6.3 Non-Fusion Technologies
11.6.4 Fracture Treatment
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Spinal Devices and Biologics Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Clinics
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Spinal Devices and Biologics Analysis and Forecast
12.1 Introduction
12.2 Latin America Spinal Devices and Biologics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Spinal Devices and Biologics Market Size Forecast by Type
12.6.1 Spinal Fusion & Fixation
12.6.2 Motion Preservation
12.6.3 Non-Fusion Technologies
12.6.4 Fracture Treatment
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Spinal Devices and Biologics Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Clinics
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Spinal Devices and Biologics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Spinal Devices and Biologics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Spinal Devices and Biologics Market Size Forecast by Type
13.6.1 Spinal Fusion & Fixation
13.6.2 Motion Preservation
13.6.3 Non-Fusion Technologies
13.6.4 Fracture Treatment
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Spinal Devices and Biologics Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Clinics
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Spinal Devices and Biologics Market: Competitive Dashboard
14.2 Global Spinal Devices and Biologics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Nuvasive
14.3.2 Orthofix International
14.3.3 Exactech
14.3.4 Wright Medical Group
14.3.5 Johnson & Johnson
14.3.6 Zimmer Biomet
14.3.7 Globus Medical
14.3.8 K2M
14.3.9 Medtronic
14.3.10 Alphatec Holdings
14.3.11 Nuvasive
